Axsome Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Hi, everyone. I think we're going to go ahead and get started. Thanks to this Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen and it is my pleasure to have with me today the team from Axsome Therapeutics. We have CEO Mark Jacobson; and CFO Nick Pizzie. So thank you both for joining us.
Maybe before we dive into the specific programs, if you guys want to start off at a high level, what's sort of the current state of the business and maybe the key catalyst that investors should be looking for, or moving parts throughout 2026.
Sure, and thanks for having us. Happy to be here today. Nick, do you want to start with maybe commercial performance run rate and --
Sure, yeah, maybe a little bit. We reported earnings a bit ago now, and mainly the focus is on Auvelity. Auvelity did for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
